165 related articles for article (PubMed ID: 32915788)
21. Predictive value of two commercial human immunodeficiency virus serological tests in cases with indeterminate Western blot results.
Huang LJ; Liu CY; Chu SC; Wong WW; Lin YC; Liu WT; Chan YJ
J Microbiol Immunol Infect; 2006 Jun; 39(3):219-24. PubMed ID: 16783452
[TBL] [Abstract][Full Text] [Related]
22. [An analysis of the blood sera of patients infected with HIV-1 for the presence of antibodies to the gp120 and gp41 sequences].
Sergeev OV; Garaev MM
Zh Mikrobiol Epidemiol Immunobiol; 1995; (4):47-51. PubMed ID: 9381871
[TBL] [Abstract][Full Text] [Related]
23. Indeterminate human immunodeficiency virus western blot results in Iranian patients with discordant screening assay results.
Ravanshad M; Mahboudi F; Sabahi F; Bayanolhagh S
Saudi Med J; 2006 Aug; 27(8):1130-3. PubMed ID: 16883439
[TBL] [Abstract][Full Text] [Related]
24. Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 ag detection: a new generation vironostika HIV Uni-Form II.
van Binsbergen J; Keur W; Siebelink A; van de Graaf M; Jacobs A; de Rijk D; Nijholt L; Toonen J; Gürtler LG
J Virol Methods; 1998 Dec; 76(1-2):59-71. PubMed ID: 9923740
[TBL] [Abstract][Full Text] [Related]
25. Human immunodeficiency virus (HIV) seropositivity among uninfected HIV vaccine recipients.
Ackers ML; Parekh B; Evans TG; Berman P; Phillips S; Allen M; McDougal JS
J Infect Dis; 2003 Mar; 187(6):879-86. PubMed ID: 12660933
[TBL] [Abstract][Full Text] [Related]
26. [Patients with an indeterminate serological diagnosis of HIV-1 infection].
Ramírez E; Soto G; Mora J; Vera L; Muñoz G; Sánchez G
Rev Med Chil; 1990 Nov; 118(11):1235-40. PubMed ID: 2152649
[TBL] [Abstract][Full Text] [Related]
27. Early and specific diagnosis of seropositivity to HIVs by an enzyme-linked immunosorbent assay using env-derived synthetic peptides.
Fenouillet E; Sorensen AM; Lacroix M; Coutellier A; Herson S; Fretz-Foucault C; Gluckman JC
AIDS; 1990 Nov; 4(11):1137-40. PubMed ID: 2282186
[TBL] [Abstract][Full Text] [Related]
28. Investigation of atypical western blot (immunoblot) reactivity involving core proteins of human immunodeficiency virus type.
Josephson SL; Swack NS; Ramirez MT; Hausler WJ
J Clin Microbiol; 1989 May; 27(5):932-7. PubMed ID: 2501354
[TBL] [Abstract][Full Text] [Related]
29. HIV‑2 antibody detection after indeterminate or negative HIV‑1 Western blot in Cuba, 2005-2008.
Díaz DF; Ortiz E; Martín D; Nibot C; Rizo A; Silva E
MEDICC Rev; 2012 Jan; 14(1):25-9. PubMed ID: 22334109
[TBL] [Abstract][Full Text] [Related]
30. Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV-1 and HIV-2 infections in an HIV-1 and HIV-2-prevalent area.
Andersson S; da Silva Z; Norrgren H; Dias F; Biberfeld G
AIDS; 1997 Dec; 11(15):1815-22. PubMed ID: 9412699
[TBL] [Abstract][Full Text] [Related]
31. Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples.
van Binsbergen J; Keur W; vd Graaf M; Siebelink A; Jacobs A; de Rijk D; Toonen J; Zekeng L; Afane Ze E; Gürtler LG
J Virol Methods; 1997 Dec; 69(1-2):29-37. PubMed ID: 9504748
[TBL] [Abstract][Full Text] [Related]
32. Complement-mediated enhancement of HIV-1 neutralisation by anti-HLA antibodies derived from polytransfused patients.
Wilfingseder D; Spruth M; Ammann CG; Döpper S; Speth C; Dierich MP; Stoiber H
Int Arch Allergy Immunol; 2003 May; 131(1):62-72. PubMed ID: 12759492
[TBL] [Abstract][Full Text] [Related]
33. Staging of recent HIV-1 infection using Geenius rapid confirmatory assay compared to INNO-LIA, New Lav and Blot 2.2 assays.
Tuaillon E; Sanosyan A; Pisoni A; Liscouët J; Makinson A; Perre PV
J Clin Virol; 2017 Oct; 95():47-51. PubMed ID: 28843384
[TBL] [Abstract][Full Text] [Related]
34. Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160.
VanCott TC; Mascola JR; Kaminski RW; Kalyanaraman V; Hallberg PL; Burnett PR; Ulrich JT; Rechtman DJ; Birx DL
J Virol; 1997 Jun; 71(6):4319-30. PubMed ID: 9151820
[TBL] [Abstract][Full Text] [Related]
35. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
Richardson TM; Stryjewski BL; Broder CC; Hoxie JA; Mascola JR; Earl PL; Doms RW
J Virol; 1996 Feb; 70(2):753-62. PubMed ID: 8551612
[TBL] [Abstract][Full Text] [Related]
36. Strategies for diagnosing HIV-1 infection in atypical Western blots.
Chen MY; Lee KL; Hung CC; Chuang CY; Chou MJ
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Aug; 30(3):135-44. PubMed ID: 10592819
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
38. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
[TBL] [Abstract][Full Text] [Related]
39. Profile of antigen-specific antibody response detectable by western blot in relation to diagnostic criteria for human immunodeficiency virus type-1 (HIV-1) infection.
Chattopadhya D; Aggarwal RK; Kumari S
Clin Diagn Virol; 1996 Oct; 7(1):35-42. PubMed ID: 9077428
[TBL] [Abstract][Full Text] [Related]
40. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals.
Mestecky J; Jackson S; Moldoveanu Z; Nesbit LR; Kulhavy R; Prince SJ; Sabbaj S; Mulligan MJ; Goepfert PA
AIDS Res Hum Retroviruses; 2004 Sep; 20(9):972-88. PubMed ID: 15585085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
